Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_assertion type Assertion NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_head.
- NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_assertion description "[Moreover, comparing both DS and non-DS AMKL with MK, we identified three potential clinical markers of progression to AMKL: TMEM241 (transmembrane protein 241) was the most over-expressed single gene, while APOC2 (apolipoprotein C-II) and ZNF587B (zinc finger protein 587B) appear to be the most discriminant markers of progression, specifically to DS AMKL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_provenance.
- NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_assertion evidence source_evidence_literature NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_provenance.
- NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_assertion SIO_000772 25476127 NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_provenance.
- NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_assertion wasDerivedFrom befree-2016 NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_provenance.
- NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_assertion wasGeneratedBy ECO_0000203 NP1244922.RAhIXy3Ti0NJux-yPO7uCBo6OS3RK5UszyA6KuJ6eFWoM130_provenance.